Article
Probiotic Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation
2022-11-29
Abstract excerpt
Lactobacillus rhamnosus (LBS) is well documented probiotic strain in oncology and has a pivotal role in clinical applications. Here we investigated the Intervention effect of Lactobacillus rhamnosus on intestinal mucositis induced by cisplatin (CP). BALB/c mice were pre-treated with or without LBS via oral gavage, followed by induction of mucositis with cisplatin. Our results revealed that LBS-treated groups signi...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer survivorship and care
- Clostridium difficile and Clostridium perfringens research
- Effects of Radiation Exposure
- Gut microbiota and health
- Helicobacter pylori-related gastroenterology studies
- Oral health in cancer treatment
- Probiotics and Fermented Foods
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 91199937-97d3-5980-a431-5b791ec11159
- DOI
- 10.21203/rs.3.rs-2310317/v1
